Investing.com - BeiGene reported on Thursday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
BeiGene announced earnings per share of $-5.2 on revenue of $100.1M. Analysts polled by Investing.com anticipated EPS of $-4.23 on revenue of $121.59M.
BeiGene shares are up 27.61% from the beginning of the year and are trading at $329.73 , down-from-52-week-high.They are outperforming the Nasdaq which is up 1.79% from the start of the year.
BeiGene follows other major Healthcare sector earnings this month
BeiGene's report follows an earnings missed by Roche Holding ADR on Monday, February 1, 2021, who reported EPS of $1.21 on revenue of $15.88B, compared to forecasts EPS of $1.28 on revenue of $16.45B.
Eli Lilly had beat expectations on Friday, January 29, 2021 with fourth quarter EPS of $2.75 on revenue of $7.44B, compared to forecast for EPS of $2.37 on revenue of $7.27B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar